134 related articles for article (PubMed ID: 11247819)
1. Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis.
Machado RD; Santos RA; Andrade SP
Am J Physiol Regul Integr Comp Physiol; 2001 Apr; 280(4):R994-R1000. PubMed ID: 11247819
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart.
Castro CH; Santos RA; Ferreira AJ; Bader M; Alenina N; Almeida AP
Hypertension; 2005 Oct; 46(4):937-42. PubMed ID: 16157793
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor.
Anton L; Merrill DC; Neves LA; Brosnihan KB
Endocrine; 2007 Oct; 32(2):212-8. PubMed ID: 18008188
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor.
De Souza AM; Lopes AG; Pizzino CP; Fossari RN; Miguel NC; Cardozo FP; Abi-Abib R; Fernandes MS; Santos DP; Caruso-Neves C
Regul Pept; 2004 Aug; 120(1-3):167-75. PubMed ID: 15177935
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Kucharewicz I; Pawlak R; Matys T; Pawlak D; Buczko W
Hypertension; 2002 Nov; 40(5):774-9. PubMed ID: 12411476
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
Souza ÁP; Sobrinho DB; Almeida JF; Alves GM; Macedo LM; Porto JE; Vêncio EF; Colugnati DB; Santos RA; Ferreira AJ; Mendes EP; Castro CH
Clin Sci (Lond); 2013 Nov; 125(9):449-59. PubMed ID: 23718715
[TBL] [Abstract][Full Text] [Related]
7. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
8. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Li P; Kondo T; Numaguchi Y; Kobayashi K; Aoki M; Inoue N; Okumura K; Murohara T
Hypertension; 2008 Feb; 51(2):252-8. PubMed ID: 18086946
[TBL] [Abstract][Full Text] [Related]
9. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
Iyer SN; Chappell MC; Averill DB; Diz DI; Ferrario CM
Hypertension; 1998 Feb; 31(2):699-705. PubMed ID: 9461243
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.
Ren Y; Garvin JL; Carretero OA
Hypertension; 2002 Mar; 39(3):799-802. PubMed ID: 11897767
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.
de Godoy MA; de Oliveira AM; Rattan S
J Pharmacol Exp Ther; 2004 Oct; 311(1):394-401. PubMed ID: 15178697
[TBL] [Abstract][Full Text] [Related]
13. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Gohlke P; Pees C; Unger T
Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
[TBL] [Abstract][Full Text] [Related]
14. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Zhang C; Hein TW; Wang W; Kuo L
Circ Res; 2003 Feb; 92(3):322-9. PubMed ID: 12595345
[TBL] [Abstract][Full Text] [Related]
15. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
[TBL] [Abstract][Full Text] [Related]
16. Analysis of responses to angiotensin I (3-10) and Leu3 angiotensin (3-8) in the pulmonary vascular bed of the cat.
Kaye AD; Nossaman BD; Smith DE; Ibrahim IN; Anwar M; Kadowitz PJ
Am J Ther; 1998 Sep; 5(5):295-302. PubMed ID: 10099072
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor.
Lara LS; Bica RB; Sena SL; Correa JS; Marques-Fernandes MF; Lopes AG; Caruso-Neves C
Regul Pept; 2002 Jan; 103(1):17-22. PubMed ID: 11738244
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.
Gironacci MM; Yujnovsky I; Gorzalczany S; Taira C; Peña C
Regul Pept; 2004 Apr; 118(1-2):45-9. PubMed ID: 14759556
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH
Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360
[TBL] [Abstract][Full Text] [Related]
20. L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells.
Yoshida M; Naito Y; Urano T; Takada A; Takada Y
Thromb Res; 2002 Mar; 105(6):531-6. PubMed ID: 12091055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
